Bone Cancer

BONE CANCER ADVISOR

HEADLINES
TREATMENT REGIMENS
DRUG INFORMATION

FEATURED CONTENT

Study Comparing Targeted With Nontargeted Therapies in Patients With Metastatic RCC May Not Account for Recent Advances in Immunotherapy

There has been a sea change in outcomes from patients treated before 2007 for renal cell carcinoma, according to an expert.
RCC in Advanced CKD: A Transplant Dilemma

Non-dialysis patients with advanced CKD diagnosed with renal malignancies grapple with the dual threat of renal failure and cancer progression.
Research Examines Breast Cancer Susceptibility Genes in Hispanic Women and Other Diverse Populations

The presence of CHEK2 or PALB2 variants in Hispanic women is enough to warrant the addition of an annual breast MRI, said study authors.
Death Rates in Melanoma Fell Markedly Following the Proliferation of New Types of Therapies

Patients are now able to get immunotherapies and targeted therapies at their local clinics, rather than having to travel to academic medical centers.
Are CTCs A Reliable Metric for Patient Stratification in Cancer?

It is still unknown whether liquid biopsies are a reliable mechanism for determining disease prognosis outside of prostate cancer.

BONE CANCER NEWS

A recent article is only the latest in a series of studies drawing attention to the importance of di

FDA Grants Orphan Drug Designation to BN-Brachyury for Chordoma

May 2, 2018

Cancer of Unknown Origin: A Diagnostic and Treatment Dilemma

CTA Treatment Regimen Chart for Bone Cancer Updated

August 9, 2016

Pacritinib induced significant and sustained spleen volume reduction and symptom control in patients

Baseline EFS Outcomes Identified for Recurrent/Refractory Pediatric Osteosarcoma

July 12, 2016

Denosumab has robust clinical efficacy in the treatment of patients with giant cell tumor of bone.

In Giant Cell Tumor of Bone, Denosumab Shows Robust Clinical Efficacy

July 24, 2015

Pacritinib induced significant and sustained spleen volume reduction and symptom control in patients

Pacritinib Reduces Spleen Volume in Patients with Myelofibrosis

May 31, 2015

Next post in General Oncology

The #MeToo movement has inspired many women to relate stories of harassment, and medicine is no exce

Female Representation on NCCN Guideline Panels Suggests Low Gender Bias